RAYMOND JAMES FINANCIAL INC
Position in NXL — Nexalin Technology, Inc.
CIK 720005
ST. PETERSBURG, FL
Position in NXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,993
-$217 QoQ
Shares Held
403
0.0% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 20 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $2,444,348,790 across 54 Medical Devices names. NXL ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
7,113,902 | $556,520,550 | |
| 2 | ABT |
Abbott Laboratories
|
5,023,587 | $455,840,283 | |
| 3 | SYK |
Stryker Corp
|
987,906 | $311,032,323 | |
| 4 | EW |
Edwards Lifesciences Corp
|
2,427,083 | $219,553,926 | |
| 5 | DXCM |
Dexcom Inc
|
3,087,990 | $207,976,124 | |
| 6 | STE |
STERIS plc
|
603,153 | $127,005,925 | |
| 7 | BSX |
Boston Scientific Corp
|
1,923,305 | $82,086,656 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
866,170 | $74,568,573 |
All Filings in NXL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,993 | 12,100 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,210 | 12,100 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||